SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Welcome to the POTP board, the DPP-IV company

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rareearth42 who wrote (63)11/22/2006 12:44:29 PM
From: drbio45  Read Replies (2) of 90
 
drbio45, You're living in a fantasy world regarding vitamin B6.

VITAMIN B6 IS PYRIDOXAL-5-PHOSPHATE, as well as the other pyridoxal variants. They are interconvertible in the body. Even if MCU's strategy works, which is highly speculative, my point is that I don't see why hospitals wouldn't buy generic pyridoxal-5-phosphate and use that intravenously instead of some branded, expensive drug. Regarding your theory that MCU is somehow using a special derivative of B6 by using pyridoxal 5 phosphate, it's wrong. Read these two paragraphs from a paper on B6 pharmacology and metabolism: Note the bolded sentence...


You are completely mixed up, if MC-1 gets approved, and you think a hospital formulary is going to buy P5P from sources other than an FDA approved product manufacturer. If you try hard enough you can find generic lipitor in china or india

Vitamin B6 functions as a coenzyme in 100 enzymatic
reactions involved in the metabolism of amino acids,
carbohydrates, neurotransmitters, and lipids (1 ). Pyridoxine
(PN),5 pyridoxal (PL), pyridoxamine (PM), their phosphorylated
derivatives [pyridoxal 5 -phosphate (PLP) and
pyridoxamine 5 -phosphate (PMP)], and the end product
of vitamin B6 metabolism, 4-pyridoxic acid (4-PA), are the
major forms of vitamin B6 found in mammalian tissues
and body fluids (1 ).
In the diet, vitamin B6 is predominantly present in
three forms, PN, PM, and PL. After passive intestinal
absorption, the major part of the vitamin is delivered to
the liver and converted to PLP (2–4). PLP is available for
other cells only after being hydrolyzed to PL by alkaline
phosphatase, but most cells have pyridoxal kinase activity
and are therefore able to rephosphorylate PL to PLP (4, 5).
Most of the PL in excess of tissue requirements is oxidized
to 4-PA by the liver and excreted in the urine (4 ).

as far as thinking you can take enough b-6 to get enough P5P into your system to get enough of a dose to get the same efficacy as mc-1 you are mistaken. to take enough b-6 that would get you 250mg of P5P into your body would cause tremendous neurotoxicity and no doctor would prescribe it.
Unless you want to continue this further I don't think I have anything to add.
This is the point board. IF you want to know the truth I have probably known about this company for 5 years and have made a lot of money on the stock. I can't believe what is happening to the price. they really screwed up the financing. The drug works

If MCU has a successful phase 3 trial, which I don't think will happen, it will be sheer luck, as there's no mechanism known by which vitamin B6 would work. The company is based on phenomenology. It's tough enough to do drug discovery and development when the science is well-understood. MCU is just playing roulette and betting on 00.

The fact that two doses showed efficacy, and the FDA is accepting their phase 2 as a pivotal trial, reinforces that your last paragraph is written out of frustration with no knowlege of the facts

Happy Thanksgiving
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext